Physician

Manish Sharda, DO

According to 2025 Medicare claims, Manish Sharda, DO (NPI: 1255728150) practices family practice in the Fond du Lac, WI market, with the plurality of this provider's patient population coming from Fond Du Lac, WI. This provider's primary affiliated billing organization is AGNESIAN HEALTHCARE INC (NPI: 1730162991; TIN: 390807236) and primary practice location at 53963-1702. Sharda is affiliated with the SSM WI ACO LLC (ACO ID: A5124), participating under the MSSP model.

Sharda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 289 traditional Medicare patients, billed 1,312 HCPCS/CPT codes, and received $98,462 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 16,230 prescription claims across 763 beneficiaries totaling $1,340,300 in drug costs, led by Eliquis (Apixaban). DME data shows 266 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,117 to $98,462. Similarly, Part D prescription costs have moved sharply higher in recent years, from $645 to $1,340,300. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $395 to $20,290.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	55	107	$6,117
2019	128	317	$17,157
2020	144	418	$24,236
2021	413	1,384	$89,885
2022	328	1,389	$89,587
2023	313	1,313	$94,747
2024	289	1,312	$98,462

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	26	$645
2016	19	71	$4,160
2017	39	149	$9,858
2018	93	262	$29,352
2019	190	1,463	$147,088
2020	286	3,297	$267,462
2021	785	12,798	$990,546
2022	805	15,577	$1,257,082
2023	764	15,770	$1,404,760
2024	763	16,230	$1,340,300

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	71	$2,386
2021	41	158	$2,802
2022	69	383	$12,430
2023	63	342	$13,774
2024	42	266	$16,703

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	215	215	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	212	363	$85
90653	Influenza vaccine, inactivated	80	80	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	166	255	$58
G0008	Administration of influenza virus vaccine	86	87	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	167	10,456	$191,071
Trulicity	Dulaglutide	87	3,780	$127,259
Ozempic	Semaglutide	62	3,661	$113,247
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	65	3,150	$67,394
Jardiance	Empagliflozin	55	2,995	$58,013

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	29	$10,495
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	16	$1,855
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	25	$1,338
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	30	66	$983
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	35	$854

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Manish Sharda, DO?

Tedicare shows public-source Medicare data for Manish Sharda, DO (NPI 1255728150), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manish Sharda, DO have ACO affiliation data?

Manish Sharda, DO is shown with ACO affiliation data for SSM WI ACO LLC (MSSP, ACO ID A5124).

What billing organization is linked to Manish Sharda, DO?

Manish Sharda, DO is linked to AGNESIAN HEALTHCARE INC (billing NPI 1730162991) in the available physician profile data.

Does Manish Sharda, DO have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.